Accessibility Menu
Tian'an Pharmaceutical logo

Tian'an Pharmaceutical(OTC) TNPH

Current Price$0.01
Market Cap$7.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-99%
5 Year-85%
1 Year+275%
1 Month-14%
Tian'an Pharmaceutical last closing stock price
MetricPriceDate
Last closeUSD 0.012026-06-26
Tian'an Pharmaceutical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-14.29%USD 0.012026-06-08
1 month-14.29%USD 0.012026-05-26
3 month-13.46%USD 0.012026-03-25
Year to date+172.73%USD 0.002025-12-24
1 year+275%USD 0.002025-06-10
3 year+11.11%USD 0.012023-06-16
5 year-85%USD 0.062021-06-11
Since inception-99.05%USD 0.952007-06-22

Tian'an Pharmaceutical Financials at a Glance

Market Cap

$7.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$510.00

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.25 (High)

Price

$0.01

Volume

11,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

May 15, 2024

TNPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tian'an Pharmaceutical

Tian'an Pharmaceutical Co., Ltd. is a company focused on the development, manufacturing, and sale of traditional Chinese herbal medicines. The company offers a range of products aimed at treating and preventing various diseases, primarily in China.

Products and Services
  • Traditional Chinese herbal medicines including capsules and ointments
  • Research and development of biological goods and health care products
  • Notable products include Compound Ginseng capsule and Tianan Pain Relief Capsule
Growth Outlook
  • Continued expansion in the traditional medicine market in China
  • Investment in research and development to enhance product offerings
  • Potential for increased market share through strategic partnerships
Financial Highlights
  • Recent quarterly net income of -$3,906, indicating ongoing operational challenges
  • Trailing twelve months (TTM) return on assets at 5.08%, showcasing asset efficiency
  • Current ratio of 0.013, highlighting liquidity concerns
Tian'an Pharmaceutical Co., Ltd. operates in the medical and pharmaceutical industry, specializing in traditional Chinese medicine. The company has a diverse product line that includes herbal capsules and ointments, which are designed to address various health issues. Despite facing financial challenges, such as negative net income in recent quarters, the company maintains a focus on growth through research and development. The return on assets suggests some efficiency in utilizing assets, although liquidity remains a concern with a low current ratio. Overall, the company presents a unique opportunity in the traditional medicine sector, with potential for future growth as it navigates its financial landscape.
AI Generated • Jul 5, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

3

CEO

Jian Jun Weng

Website

www.xatazy.com

Headquarters

Reno, NC 27517, US

TNPH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

4.99%

Return on Capital

N/A

Return on Assets

-67.91%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

800.00M

Volume

11.00K

Avg. Volume

540.484

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$16.22K

EBITDA

$774.00

Operating Cash Flow

-$3.18K

Capital Expenditure

$0.00

Free Cash Flow

-$3.18K

Cash & ST Invst.

$8.00

Total Debt

$62.93K

Tian'an Pharmaceutical Performance Analysis

Tian'an Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,500N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Tian'an Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q32024-09-30N/A
Q42024-12-31N/A
Q32025-09-30N/A
Tian'an Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00-50.0%
20232023-12-31USD -0.00-66.7%
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
Tian'an Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q32024-09-30N/A
Q42024-12-31N/A
Q32025-09-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.40M

N/A

Employees

3

N/A

Net Income

-$3.91K

+33.0%

EBITDA

-$3.91K

+35.9%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$8.00

-97.0%

Total Debt

$62.93K

+17.7%

Accounts Receivable

$1.31K

-61.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$62.93K

+17.7%

Return on Assets

-67.91%

N/A

Return on Invested Capital

4.63%

N/A

Free Cash Flow

-$1.97K

-136.6%

Operating Cash Flow

-$1.97K

-136.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NNRXNutranomics, Inc.
$0.00+0.00%
KALYKali, Inc.
$0.00+0.00%
CNNCCannonau Corp.
$0.00+0.00%
PTLFPetlife Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About TNPH

What is the current price of Tian'an Pharmaceutical?

Tian'an Pharmaceutical is trading at $0.01 per share.

What is the 52-week range for Tian'an Pharmaceutical?

Over the past 52 weeks, Tian'an Pharmaceutical has traded between $0.00 and $0.05.

How much debt does Tian'an Pharmaceutical have?

As of the most recent reporting period, Tian'an Pharmaceutical reported total debt of $62.93K.

How much cash does Tian'an Pharmaceutical have on hand?

Tian'an Pharmaceutical reported $8.00 in cash and cash equivalents in its most recent financial results.

What is Tian'an Pharmaceutical’s dividend yield?

Tian'an Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services